EASL – The International Liver Congress. Meet up with Gubra scientists Denise Oró dor@gubra.dk, Andreas Nygaard Madsen anm@gubra.dk, Malte Hasle Nielsen mni@gubra.dk and Michael Feigh mfe@gubra.dk.
Recent Posts
- Gubra ApS and Silence Therapeutics plc collaborate to develop RNAi therapies against novel liver-directed targets from Gubra’s streaMLine platform
- Gubra launches NeuroPedia – a mouse brain atlas for virtual neuroscience
- Gubra and Bayer AG collaborate to develop next generation cardiorenal treatments
- Drug candidate from obesity collaboration between Gubra and Boehringer Ingelheim enters clinical phase 1 trial
- Annual results 2020: A thriving core business and razor-sharp biotech profile
Recent Comments